Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mild versus standard ovarian stimulation in poor responders undergoing IVF/ICSI
NL-OMON26313Not yet recruiting
- Sponsor
- Non
- Start
- Nov 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules, Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of follitropin, human menopausal gonadotrophin, triptorelin, relugolix, human chorionic gonadotropin and 1 more in poor ovarian response (POR) and infertility (2 arms), sponsored by Non. Primary endpoint: Ongoing pregnancy rate per woman randomized. Planned start Nov 2010; status: not yet recruiting.
02
Drugs
follitropinhuman menopausal gonadotrophintriptorelinrelugolixhuman chorionic gonadotropin
03
Conditions
poor ovarian response (POR)infertility
Beyond the preview
Go deeper on NL-OMON26313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26313.